Clinical genetics in transition—a comparison of genetic services in Estonia, Finland, and the Netherlands
| Autor: | Helena Kääriäinen, Tessel Rigter, Terry Vrijenhoek, N. Tonisson, L. Leitsalu |
|---|---|
| Přispěvatelé: | Human genetics, APH - Personalized Medicine, APH - Quality of Care |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
0303 health sciences
medicine.medical_specialty Service (systems architecture) Epidemiology business.industry Emerging technologies Public health 030305 genetics & heredity Public Health Environmental and Occupational Health Context (language use) Public relations Biobank Human genetics 03 medical and health sciences Political science Health care medicine Medical genetics Original Article business Genetics (clinical) 030304 developmental biology |
| Zdroj: | Journal of Community Genetics Vrijenhoek, T, Tonisson, N, Kääriäinen, H, Leitsalu, L & Rigter, T 2021, ' Clinical genetics in transition—a comparison of genetic services in Estonia, Finland, and the Netherlands ', Journal of Community Genetics, vol. 12, no. 2, pp. 277-290 . https://doi.org/10.1007/s12687-021-00514-7 Journal of Community Genetics, 12(2), 277-290. Springer Verlag |
| ISSN: | 1868-6001 1868-310X |
| DOI: | 10.1007/s12687-021-00514-7 |
| Popis: | Genetics has traditionally enabled the reliable diagnosis of patients with rare genetic disorders, thus empowering the key role of today’s clinical geneticists in providing healthcare. With the many novel technologies that have expanded the genetic toolkit, genetics is increasingly evolving beyond rare disease diagnostics. When placed in a transition context—like we do here—clinical genetics is likely to become a fully integral part of future healthcare and clinical genetic expertise will be required increasingly outside traditional clinical genetic settings. We explore transition effects on the thinking (culture), organizing (structure), and performing (practice) in clinical genetics, taking genetic healthcare in Estonia, Finland, and the Netherlands as examples. Despite clearly distinct healthcare histories, all three countries have initially implemented genetic healthcare in a rather similar fashion: as a diagnostic tool for predominantly rare congenital diseases, with clinical geneticists as the main providers. Dynamics at different levels, such as emerging technologies, biobanks and data infrastructure, and legislative frameworks, may require development of a new system attuned with the demands and (historic) context of specific countries. Here, we provide an overview of genetic service provisions in Estonia, Finland, and the Netherlands to consider the impact of historic and recent events on prospective developments in genetic healthcare. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink